Catalyst Wire Dossier Catalyst Wire Dossier

RegenoGel-SP

· ProCore Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RegenoGel-SP, covering 2017-04-27 to 2017-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I, Prospective, Randomized, Open-label, Active-Controlled Clinical Trial for Safety Evaluation of Intra-articular Injection of RegenoGel-SP for the Treatment of Moderate to Severe Osteoarthritis [Phase 1, Phase 2]

See pricing